Transgenic Group Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	12,893	13,005	13,083	11,429	12,576	11,046
Revenue Growth (YoY)	-1.93%	-0.60%	14.47%	-9.12%	13.85%	-
Cost of Revenue	10,595	10,838	10,835	9,435	8,741	8,269
Gross Profit	2,298	2,167	2,248	1,994	3,835	2,777
Selling, General & Admin	2,326	2,426	2,159	2,019	1,998	1,883
Operating Expenses	2,326	2,422	2,146	2,019	1,998	1,881
Operating Income	-28	-255	102	-25	1,837	896
Interest Expense	-46	-37	-47	-28	-22	-28
Interest & Investment Income	2	1	-	-	-	2
Currency Exchange Gain (Loss)	8	7	39	-	20	-
Other Non Operating Income (Expenses)	-1	-35	14	253	-17	22
EBT Excluding Unusual Items	-65	-319	108	200	1,818	892
Gain (Loss) on Sale of Investments	127	-10	-	-13	1,343	-71
Gain (Loss) on Sale of Assets	1	1	-3	34	-	21
Asset Writedown	-279	-284	-2	-242	-671	-110
Legal Settlements	-173	-49	-59	-	-	-
Other Unusual Items	-34	-14	-1	-310	277	-37
Pretax Income	-423	-675	43	-331	2,767	695
Income Tax Expense	360	414	39	108	907	152
Earnings From Continuing Operations	-783	-1,089	4	-439	1,860	543
Minority Interest in Earnings	13	-	-	30	16	3
Net Income	-770	-1,089	4	-409	1,876	546
Net Income to Common	-770	-1,089	4	-409	1,876	546
Net Income Growth	-	-	-	-	243.59%	-
Shares Outstanding (Basic)	17	17	17	17	17	17
Shares Outstanding (Diluted)	17	17	17	17	17	17
Shares Change (YoY)	0.18%	-1.00%	-0.25%	-1.87%	-1.18%	0.01%
EPS (Basic)	-46.24	-65.47	0.24	-24.28	109.50	31.44
EPS (Diluted)	-46.24	-65.47	0.24	-24.28	109.31	31.44
EPS Growth	-	-	-	-	247.70%	-
Free Cash Flow	-	-81	-656	-1,736	1,257	1,077
Free Cash Flow Per Share	-	-4.87	-39.04	-103.06	73.23	62.00
Dividend Per Share	-	-	3.000	3.000	3.000	3.000
Gross Margin	17.82%	16.66%	17.18%	17.45%	30.49%	25.14%
Operating Margin	-0.22%	-1.96%	0.78%	-0.22%	14.61%	8.11%
Profit Margin	-5.97%	-8.37%	0.03%	-3.58%	14.92%	4.94%
Free Cash Flow Margin	-	-0.62%	-5.01%	-15.19%	9.99%	9.75%
EBITDA	282	-14	251	157	2,064	1,147
EBITDA Margin	2.19%	-0.11%	1.92%	1.37%	16.41%	10.38%
D&A For EBITDA	310	241	149	182	227	251
EBIT	-28	-255	102	-25	1,837	896
EBIT Margin	-0.22%	-1.96%	0.78%	-0.22%	14.61%	8.11%
Effective Tax Rate	-	-	90.70%	-	32.78%	21.87%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.